EUVIMEDEUVIMED entdecken
Crossref

Immunosuppressive role of ascites fluid in the ovarian cancer microenvironment: targeting myeloid-derived suppressor cells as a strategy to restore sensitivity to immunotherapy

Anna D. Kuznetsova, Anna E. Managarova, Zainab M. Kurbanova, Darya A. Mogilina, Irina Yu. Astakhova, Anna I. Girya, Albina D. Albotova, Ekaterina I. Esaulova, Yana A. Bukhtoyarova, Anastasia A. Budunova, Silvira M. Sazhidova, Ridzhal A. Sidikov und 1 weitere

V.F.Snegirev Archives of Obstetrics and Gynecology · 14.11.2026 · 13 (3) · 211-221

DOI: 10.17816/aog697267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift V.F.Snegirev Archives of Obstetrics and Gynecology, online erschienen am 14.11.2026. Verfasst von Anna D. Kuznetsova und 12 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer is one of the most dangerous and common gynecological malignancies in the world. At the time of diagnosis, most patients have concomitant malignant ascites and late-stage disease. This scientific review analyzes the immunosuppressive function of ascitic fluid in the cellular microenvironment of ovarian cancer, with a focus on the role of myeloid-derived suppressor cells. The molecular and cellular mechanisms are considered by which the constituent elements of the microenvironment in ascites, including cytokines, chemokines, and metabolites, induce chemotaxis and functional activation of suppressor cells, leading to suppression of antitumor immunity through inhibitory effects on cytotoxic T lymphocytes and other immune cells. This review of publications focuses on current therapeutic strategies aimed at selectively modulating myeloid cells using inhibitors of signaling pathways, growth factors, and immunomodulators. The article also explores biomarkers of myeloid-derived suppressor cells that can serve as predictors of therapeutic efficacy and disease prognosis. The prospects for developing targeted immunotherapeutic approaches to overcome immunosuppression and promote favorable clinical outcomes in patients with ovarian cancer are discussed.

Zitieren

APA

Kuznetsova, A. D., Managarova, A. E., Kurbanova, Z. M., Mogilina, D. A., Astakhova, I. Y., Girya, A. I., Albotova, A. D., Esaulova, E. I., Bukhtoyarova, Y. A., Budunova, A. A., Sazhidova, S. M., Sidikov, R. A., & Sugaipova, M. V. (2026). Immunosuppressive role of ascites fluid in the ovarian cancer microenvironment: targeting myeloid-derived suppressor cells as a strategy to restore sensitivity to immunotherapy. V.F.Snegirev Archives of Obstetrics and Gynecology, 13(3), 211-221. https://doi.org/10.17816/aog697267

Vancouver

Kuznetsova AD, Managarova AE, Kurbanova ZM, Mogilina DA, Astakhova IY, Girya AI, et al. Immunosuppressive role of ascites fluid in the ovarian cancer microenvironment: targeting myeloid-derived suppressor cells as a strategy to restore sensitivity to immunotherapy. V.F.Snegirev Archives of Obstetrics and Gynecology. 2026;13(3):211-221. doi:10.17816/aog697267

BibTeX
@article{Kuznetsova2026,
  author = {Kuznetsova, Anna D. and Managarova, Anna E. and Kurbanova, Zainab M. and Mogilina, Darya A. and Astakhova, Irina Yu. and Girya, Anna I. and Albotova, Albina D. and Esaulova, Ekaterina I. and Bukhtoyarova, Yana A. and Budunova, Anastasia A. and Sazhidova, Silvira M. and Sidikov, Ridzhal A. and Sugaipova, Makka V.},
  title = {Immunosuppressive role of ascites fluid in the ovarian cancer microenvironment: targeting myeloid-derived suppressor cells as a strategy to restore sensitivity to immunotherapy},
  journal = {V.F.Snegirev Archives of Obstetrics and Gynecology},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {211--221},
  doi = {10.17816/aog697267}
}
Kostenlos starten →